© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, OKYO Pharma Limited (OKYO) shows an Average True Range (ATR) of 0.21 and an Enterprise Value of 45.88M. Its average trading volume over the past 3 months is 154.29K, indicating liquidity. These fundamental metrics provide insight into OKYO's underlying financial health and market activity.
OKYO Pharma Limited (OKYO) technical indicators as of December 22, 2025: the SMA 20 is 4%, SMA 50 at -7.85%, and SMA 200 at -2.45%. The RSI 14 value is 49.72, suggesting its current momentum. These technical analysis signals help assess OKYO's price trends and potential future movements.
OKYO Pharma Limited (OKYO) stock performance overview as of December 22, 2025: The 52-week high is $3.35 (currently -39.38% below), and the 52-week low is $0.902 (currently 125.16% above). Over the past year, OKYO's performance is 91.51%, compared to the S&P 500's 12.87% change.
According to market data, OKYO Pharma Limited (OKYO) stock's recent performance metrics show that over the last month, OKYO is -4.69%, with a Year-to-Date (YTD) performance of 76.52%. Over the past year, the stock has seen a 91.51% change. These figures summarize OKYO's price movements across various periods, reflecting its historical returns.
According to current financial data, OKYO stock's P/E (TTM) ratio is -17.03, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for OKYO, including P/S (N/A), P/B (-14.44), and P/FCF (-42.11), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.